-
1
-
-
16544369317
-
Prothrombin 20210 mutation (factor II mutation)
-
Varga EA, Moll S. Prothrombin 20210 mutation (factor II mutation). Circulation. 2004; 110: e15-e18.
-
(2004)
Circulation
, vol.110
-
-
Varga, E.A.1
Moll, S.2
-
2
-
-
1942531427
-
Hyperhomocysteinemia and other newly recognized inherited coagulation disorders in patients with idiopathic cerebral vein thrombosis
-
Ventura P, Cobelli M, Marietta M, Panini R, Rosa MC, Salvioli G. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders in patients with idiopathic cerebral vein thrombosis. Cerebrovasc Dis. 2004; 17: 153-9.
-
(2004)
Cerebrovasc Dis
, vol.17
, pp. 153-159
-
-
Ventura, P.1
Cobelli, M.2
Marietta, M.3
Panini, R.4
Rosa, M.C.5
Salvioli, G.6
-
3
-
-
0344013602
-
Venous thrombosis and thrombophilic management of prevention and therapy
-
Ruef J, Katus HA. Venous thrombosis and thrombophilic management of prevention and therapy. Hamostaseologie. 2003; 23: 186-98.
-
(2003)
Hamostaseologie
, vol.23
, pp. 186-198
-
-
Ruef, J.1
Katus, H.A.2
-
4
-
-
4644252481
-
Epidemiology, etiology and diagnosis of venous thrombosis
-
Gathof BS, Picker SM, Rojo J. Epidemiology, etiology and diagnosis of venous thrombosis. Eur J Med Res. 2004; 9: 95-103.
-
(2004)
Eur J Med Res
, vol.9
, pp. 95-103
-
-
Gathof, B.S.1
Picker, S.M.2
Rojo, J.3
-
5
-
-
1842452944
-
Genetics of thrombophilia: Impact on atherogenesis
-
Voetsch B, Loscalzo J. Genetics of thrombophilia: impact on atherogenesis. Curr Opin Lipidol. 2004; 15: 129-43.
-
(2004)
Curr Opin Lipidol
, vol.15
, pp. 129-143
-
-
Voetsch, B.1
Loscalzo, J.2
-
6
-
-
0142053972
-
From vulnerable plaque to vulnerable patient
-
Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient. Circulation. 2003; 108: 1772.
-
(2003)
Circulation
, vol.108
, pp. 1772
-
-
Naghavi, M.1
Libby, P.2
Falk, E.3
Casscells, S.W.4
Litovsky, S.5
Rumberger, J.6
-
7
-
-
0037069779
-
Prediction of the risk of myocardial infarction for polymorphisms in cadidate genes
-
Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, et al. Prediction of the risk of myocardial infarction for polymorphisms in cadidate genes. N Engl J Med. 2002; 347: 1916-23.
-
(2002)
N Engl J Med
, vol.347
, pp. 1916-1923
-
-
Yamada, Y.1
Izawa, H.2
Ichihara, S.3
Takatsu, F.4
Ishihara, H.5
Hirayama, H.6
-
8
-
-
1342311289
-
Myocardial infarction as an initial symptom of antiphospholipid syndrom, factor V mutation, and hyperhomocystenemia
-
Dropinski J, Wegrzyn W, Szczeklik W, Krzanowski M. Myocardial infarction as an initial symptom of antiphospholipid syndrom, factor V mutation, and hyperhomocystenemia. Pol Arch Med Wewn. 2004; 111: 63-7.
-
(2004)
Pol Arch Med Wewn
, vol.111
, pp. 63-67
-
-
Dropinski, J.1
Wegrzyn, W.2
Szczeklik, W.3
Krzanowski, M.4
-
9
-
-
0035877010
-
Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases
-
Wu A, Tongalis G. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol. 2001; 87: 1361-6.
-
(2001)
Am J Cardiol
, vol.87
, pp. 1361-1366
-
-
Wu, A.1
Tongalis, G.2
-
10
-
-
0242636998
-
Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter
-
Sakurai K, Hirai T, Nakagawa K, Kameyama T, Nozawa T, Asanoi H, et al. Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter. Chest. 2003; 124: 1670-4.
-
(2003)
Chest
, vol.124
, pp. 1670-1674
-
-
Sakurai, K.1
Hirai, T.2
Nakagawa, K.3
Kameyama, T.4
Nozawa, T.5
Asanoi, H.6
|